Breaking News
September 25, 2018 - Gene therapy approach could help treat mitochondrial diseases
September 25, 2018 - Few Yogurt Products Qualify As Low-Sugar
September 25, 2018 - Eye disease can cause blindness, and it’s on the rise
September 25, 2018 - Pawnshop density linked to gun-related suicides, Stanford study finds
September 25, 2018 - Pioneering procedure for common prostate condition offered by The London Clinic
September 25, 2018 - Number of people with respiratory diseases likely to increase if UK air pollution remains unchecked
September 25, 2018 - FARXIGA receives positive results in Phase III DECLARE-TIMI 58 cardiovascular outcomes trial
September 25, 2018 - New program to reduce harmful stress effectively improves mood in cancer patients
September 24, 2018 - Florence’s Lingering Threat: Mold – Drugs.com MedNews
September 24, 2018 - For professional baseball players, faster hand-eye coordination linked to batting performance
September 24, 2018 - Bill for later school start times is defeated, but Stanford sleep specialist isn’t
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Successful recovery from addiction means more than achieving abstinence
September 24, 2018 - New nanoplatform technology may reverse drug-resistance in renal cell carcinoma
September 24, 2018 - October 1918 marks the centenary of Spanish Flu that claimed more lives than World War I
September 24, 2018 - LGBT community reports more number of poor mental health days than general population
September 24, 2018 - New research suggests power of zebrafish as tool for cancer drug discovery
September 24, 2018 - New study finds height as possible risk factor for developing varicose veins
September 24, 2018 - Researchers compare weight loss results of online and in-person diabetes prevention program
September 24, 2018 - New HER2 PET Study Uses Affibody’s ABY-025 Tracer to Individualize Breast Cancer Treatment
September 24, 2018 - Drug combination offers more effective care for patients suffering miscarriage
September 24, 2018 - Tallness linked to varicose veins, Stanford study says
September 24, 2018 - For Heart Failure Patients, Mitral Valve Procedure Improved Outcomes
September 24, 2018 - Ecstasy drug makes octopuses more social
September 24, 2018 - Immediate compression therapy could cut risk of complications after deep-vein thrombosis
September 24, 2018 - Transcatheter mitral valve repair reduces mortality for patients with mitral regurgitation
September 24, 2018 - First intracranial aneurysm patients treated with BRAVO Flow Diverter after CE mark approval
September 24, 2018 - ‘Physicians of the mouth’? Dentists absorb the medical billing drill
September 24, 2018 - People more likely to believe those with confident tone of voice than with accent
September 24, 2018 - Harmony Biosciences Presents 5-Year Data On Pitolisant At International Narcolepsy Symposium
September 24, 2018 - Blood test may identify gestational diabetes risk in first trimester
September 24, 2018 - Height may be risk factor for varicose veins | News Center
September 24, 2018 - King’s commemorates opening of new NMR facility with one-day symposium
September 24, 2018 - Eisai receives approval for partial label change of DC Bead device for transcatheter arterial embolization
September 24, 2018 - High-resolution genomic map gives scientists unprecedented view of brain development
September 24, 2018 - Researchers find impact of neurobehavioral symptoms on employment in adults with TBI
September 24, 2018 - Alexion announces positive results from Phase 3 PREVENT study of Soliris in patients with NMOSD
September 24, 2018 - First evaluation of benefits, harms of Alzheimer’s screening for family members of older adults
September 24, 2018 - Ancora Heart announces positive data of study evaluating AccuCinch Ventricular Repair System
September 24, 2018 - Children of mothers using cannabis may start using it at an earlier age, finds study
September 24, 2018 - Gilead Sciences plans to launch authorized generic versions of Epclusa and Harvoni in the US
September 24, 2018 - Most patients who underwent transcatheter valve replacement experience prosthesis-patient mismatch
September 24, 2018 - Lumos acquires license for LUM-201 drug that promotes secretion of growth hormone
September 24, 2018 - New study provides basis for Air Canada to change its facial hair policy for aircrew
September 24, 2018 - Infant walkers lead to thousands of emergency visits for babies
September 24, 2018 - Genes predicting person’s height may provide clues about causes of varicose veins
September 24, 2018 - EPA Plan Will Maintain Carbon Emissions From Power Plants
September 24, 2018 - Characterizing pig hippocampus could improve translational neuroscience
September 24, 2018 - Element3 Health reports social and mental engagement play key role in overall health
September 24, 2018 - Paralympic medalists support Fight for Sight’s unique virtual event
September 24, 2018 - ADCETRIS drug receives approval in Japan as frontline treatment option for Hodgkin lymphoma
September 24, 2018 - Public awareness of urological conditions found to be alarmingly low across Europe
September 24, 2018 - Fitter Folks Suffer Milder Strokes: Study
September 24, 2018 - Novel botulinum toxin compound relieves chronic pain
September 24, 2018 - CHMP recommends approval of Gilenya for treatment of multiple sclerosis in children, adolescents
September 24, 2018 - National Friendly’s private medical insurance is a hit with women living in the South East
September 24, 2018 - Academics receive prestigious awards for achievements in blood pressure research
September 24, 2018 - Obese pregnant women can restrict weight gain safely with proper nutrition guidance
September 24, 2018 - CHMP adopts positive opinion of Takeda’s ALUNBRIG for treatment of ALK+ non-small cell lung cancer
September 24, 2018 - China NMPA approves LENVIMA for treatment of unresectable hepatocellular carcinoma
September 24, 2018 - A new approach for finding Alzheimer’s treatments
September 24, 2018 - USC research uncovers previously unknown genetic risk factor for dementia
September 24, 2018 - Study examining mental health among students finds significant disparities in treatment across race
September 24, 2018 - Breakthrough discovery paves way for future test to identify drowsy drivers
September 24, 2018 - Transcatheter mitral-valve repair in patients with heart failure
September 24, 2018 - Study opens new avenues for treatment of Laing distal myopathy
September 24, 2018 - Stroke Facts | cdc.gov
September 24, 2018 - Sarcolipin tricks muscle cells into using more energy, burning fat
September 24, 2018 - Enrollment in opioid controlled substance agreement reduces primary care visits
September 24, 2018 - UTA researchers patent new smart seat cushion technology that helps prevent painful ulcers
September 24, 2018 - Second HPV-Related Primary Cancers Common in Survivors
September 24, 2018 - How a virus destabilizes the genome
September 24, 2018 - Old letters provide insight into Spanish flu pandemic horror
September 23, 2018 - Smart textile-based soft robotic exosuit helps wearers save energy and traverse difficult terrain
September 23, 2018 - New research hub to drive radical change in development and manufacturing of vaccines
September 23, 2018 - AHA: For Hispanics, Neighborhood May Be Key Factor in Heart Disease Risk
September 23, 2018 - Excessive airway nerves tied to more severe asthma symptoms, study finds
September 23, 2018 - Study highlights need to remain vigilant in maintaining key infection control processes
September 23, 2018 - Novel therapeutic strategy for blood vessel related disorders, such as cancer and retinopathy
September 23, 2018 - New naturally occurring antibiotic found effective against Mycobacterium tuberculosis
One-shot osteoarthritis drug investigated

One-shot osteoarthritis drug investigated

image_pdfDownload PDFimage_print
Lately, there is not any remedy for osteoarthritis, the commonest joint downside in the US. A brand new find out about brings hope of a single-injection repair. The drug on trial clears out previous cells from the joints.
[Black man osteoarthritis knee pain]
Analysis reveals new OA drug is in a position to kill previous cells.

Osteoarthritis (OA) is one of those arthritis that happens when cartilage on the ends of bones wears down. It may possibly have an effect on any joint within the frame, however it maximum often impacts the palms, neck, decrease again, knees, and hips.

In other folks over the age of 60, OA happens in 10 p.c of guys and 13 p.c of ladies.

OA can expand because of basic put on and tear on tissues from years of use, and subsequently, chance will increase as we age. On the other hand, the situation will also be brought about by way of damage or surgical intervention.

Since the reasonable age of the inhabitants is continuously expanding and because of the upward push in weight problems ranges, OA circumstances are expanding in line.

Present therapies can assist sufferers to regulate their signs, however the underlying processes cannot be reversed. A contemporary find out about, revealed in Nature Drugs, investigates whether or not a drug that gets rid of senescent, or previous, cells from the joint may well be helpful within the remedy of OA.

Senescent cells key to OA drug

Senescent cells naturally building up in our our bodies as we age. They’re a regular a part of damage restore and wound therapeutic. By means of secreting positive indicators, more than a few mobile sorts are alerted and migrate to the broken area to start out maintenance.

Sadly, senescent cells in joints don’t seem to be at all times cleared from the realm as soon as the damage is repaired. By means of staying well past their welcome, the senescent cells cause a “cascade of occasions,” culminating within the construction of OA.

One of the vital researchers within the present find out about was once Jennifer Elisseeff, Ph.D., director of the Translational Tissue Engineering Middle and Morton Goldberg Professor of Ophthalmology on the Johns Hopkins Wilmer Eye Institute in Baltimore, MD. She says: “Mix age-related will increase in senescent cells, plus trauma, and it is a double whammy.”

For the find out about, the workforce first carried out surgical procedure on younger mice: they minimize their anterior cruciate ligaments, mimicking an damage.

Fourteen days later, as soon as osteoarthritic adjustments had been below means, they injected a drug into the mice’s joints. The drug, snappily named UBX0101, has been proven to in particular kill senescent cells.

The workforce discovered that the mice that gained UBX0101 had a 50 p.c aid in senescent cells.

As a double take a look at, the workforce monitored gene expression within the mice following UBX0101 remedy, and the genes related to cartilage expansion had been proven to be activated within the joint.

Following on from the experiments on more youthful mice, the workforce performed equivalent trials on older mice. The older mice had thinner cartilage than the more youthful mice, they usually additionally had larger ranges of ache firstly of the experiment. When they were injected with UBX0101, that they had a discount in ache, however they didn’t display the similar indicators of cartilage regeneration.

UBX0101 in human tissue

After all, your next step was once to look at whether or not UBX0101 may have a equivalent impact on human tissue. The researchers subsequently examined the drug on cultures of cartilage cells, taken from other folks with critical OA. Those cultures had been then grown into three-D constructions to imitate how the tissue grows in vivo.

After four days of publicity to UBX0101, the choice of senescent cells was once considerably decreased and, importantly, new cartilage started to shape.

‘What was once maximum placing concerning the ends up in human tissue is the truth that removing of senescent cells had a profound impact on tissue from very complex osteoarthritis sufferers, suggesting that even sufferers with complex illness may get advantages.”

Jennifer Elisseeff, Ph.D.

The effects had been spectacular and the drug displays actual promise. Lately, alternatively, there’s a stumbling block: UBX0101 does now not spend a lot time within the joint. In an try to go this bridge, Team spirit Biotechnology, who helped to expand the drug, are “running on single-injection formulations.”

This may, someday, imply that sufferers would want only one dose of remedy for OA. As Elisseeff explains: “Since the drug goals and kills the senescent cells immediately, as soon as they’re eradicated, sufferers won’t want to go back for widespread therapies.”

There’s nonetheless numerous flooring to hide sooner than this kind of remedy is to be had, however it without a doubt gives a wholesome portion of hope.

Find out how OA may well be related to a high-fat vitamin.

Tagged with:

About author

Related Articles